Solid Biosciences Inc.SLDBNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+15.8%
5Y CAGR+16.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+15.8%/yr
vs +10.9%/yr prior
5Y CAGR
+16.6%/yr
Consistent
Acceleration
+4.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $177.95M | +39.8% |
| 2024 | $127.27M | +25.1% |
| 2023 | $101.73M | -11.2% |
| 2022 | $114.55M | +33.4% |
| 2021 | $85.87M | +4.0% |
| 2020 | $82.54M | -30.8% |
| 2019 | $119.32M | +57.6% |
| 2018 | $75.69M | +38.0% |
| 2017 | $54.86M | +114.5% |
| 2016 | $25.58M | - |